Indaptus Therapeutics
INDP
INDP
8 hedge funds and large institutions have $10.2M invested in Indaptus Therapeutics in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$2.95M |
| 2 |
OM
2
Opaleye Management
Boston,
Massachusetts
|
$2.63M |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$3K |
Top Sellers
| 1 |
PA
1
Perceptive Advisors
New York
|
$795K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$12K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $3.3M | 800,000 | – | – |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $2.95M | 714,062 | +43,613 | +7% |
|
|
OM
3
Opaleye Management
Boston,
Massachusetts
| $2.63M | 638,000 | +8,000 | +1% |
|
|
PA
4
Perceptive Advisors
New York
| $795K | 192,580 | -82,420 | -30% |
|
|
DCM
5
DAFNA Capital Management
Los Angeles,
California
| $491K | 119,296 | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $12K | 2,902 | -1,200 | -29% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $3K | 712 | +712 | New |
|
8
Citigroup
New York
| – | – | -1 | Closed |
|
9
Morgan Stanley
New York
| $0 | 19 | – | – |
|